Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting ...

Craig Collins struggled with his condition before committing to the long path through surgeries—and fitness—to muscle up.

Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...

Eli Lilly has claimed FDA approval for its IL-23 inhibitor Omvoh as a treatment for moderately to severely active Crohn's ...

In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...

The FDA has approved Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohn’s disease in adults. Clinical ...

A study may explain why some patients with Crohn's disease continue to experience symptoms ... presence of inflammation -- nearly one-third of all patients report persistent symptoms.

Eating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...

But imagine doing all that while dealing with Crohn’s Disease as well… That is exactly what Gigi had to do. Crohn’s is a type of Inflammatory Bowel Disease (IBD) where parts of the gut ...

The resulting paper, "Why Symptoms Linger in Quiescent Crohn's Disease: Investigating the Impact ... of inflammation—nearly one-third of all patients report persistent symptoms.

Crohn’s disease and ulcerative colitis (UC) are both types of inflammatory bowel disease (IBD) that share similar symptoms but differ in their affected areas, disease progression, and treatment ...